Not Signed In - No Benefit For Liver Cancer Patients From Long-acting Octreotide
Thu, 04 Jan 2007 04:00 AM EST
... Long-acting octreotide does not improve outcomes for patients with liver cancer compared to a placebo, according to the results of a new double blind study published in the January 2007 issue of Hepatology, the official journal of the American Association for the Study of Liver Diseases (AASLD). ...
Related Topics
- Liver Cancer
- Long-Acting Anticoagulant
- Metastatic Cancer
- Liver Disease
- Long Term Care
- Cancers
- Liver Biopsy
- Kidney Cancer
- Pancreatic Cancer
- Smoking Cessation and Continued Risk in Cancer Patients
- Milk Thistle
- Childhood Cancers
- Cancer Clusters
- Hepatocellular
- Childhood Liver Cancer
- Liver Cancer, Childhood
- Bile Duct Cancer
- Liver Transplantation
- Cancer
- Liver Diseases And Disorders
email this page
print this page
bookmark this page
feedback on this page
